Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 3/2014

01.09.2014 | Review Article

Blood Substitutes: Possibilities with Nanotechnology

verfasst von: Feroz Alam, Neha Yadav, Murad Ahmad, Mariyam Shadan

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Nanotechnology deals with molecules in the nanometer (10−9) range and is currently being used successfully in the field of medicine. Nanotechnology has important implications in nearly all the branches of medicine and it has all the capabilities to revolutionize the vast field of medicine in future. Nanotechnological advancements have been used for the preparation of artificial hemoglobin. It is formed by assembling the hemoglobin molecules into a soluble complex. A recent approach includes the assembling of this artificial hemoglobin with enzymes such as catalase and superoxide dismutase into a nano-complex. This complex acts as an oxygen carrier as well as an antioxidant in conditions with ischemia–reperfusion injuries.
Literatur
1.
Zurück zum Zitat Aggarwal S, Sharma V (2012) Attitudes and problems related to voluntary blood donation in India: a short communication. Ann Trop Med Public Health 5:50–52 Aggarwal S, Sharma V (2012) Attitudes and problems related to voluntary blood donation in India: a short communication. Ann Trop Med Public Health 5:50–52
3.
Zurück zum Zitat Chaitanya kumar IS, Yashoverdhan (2011) Efforts to meet the challenges of 100 % voluntary blood donation. Asian J Transfus Sci 5:68–69CrossRef Chaitanya kumar IS, Yashoverdhan (2011) Efforts to meet the challenges of 100 % voluntary blood donation. Asian J Transfus Sci 5:68–69CrossRef
5.
Zurück zum Zitat Geyer RP, Monroe RG, Taylor K (1968) Survival of rats having red cells totally replaced with emulsified fluorocarbon. Federation Proc 27:384–390 Geyer RP, Monroe RG, Taylor K (1968) Survival of rats having red cells totally replaced with emulsified fluorocarbon. Federation Proc 27:384–390
6.
Zurück zum Zitat Sloviter H, Kamimoto T (1967) Erythrocyte substitute for perfusion of brain. Nature 216:458–460PubMedCrossRef Sloviter H, Kamimoto T (1967) Erythrocyte substitute for perfusion of brain. Nature 216:458–460PubMedCrossRef
7.
Zurück zum Zitat Keipert PE (1998) Perfluorochemical emulsions: future alternatives to transfusion. Blood Subst Princ Meth Prod Clin Trials 2:127–156 Keipert PE (1998) Perfluorochemical emulsions: future alternatives to transfusion. Blood Subst Princ Meth Prod Clin Trials 2:127–156
8.
Zurück zum Zitat Spahn DR, Leone BJ, Reves JG, Pasch T (1994) Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 78:1000–1021PubMedCrossRef Spahn DR, Leone BJ, Reves JG, Pasch T (1994) Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 78:1000–1021PubMedCrossRef
9.
Zurück zum Zitat Riess JG (1992) Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Biomater Artif Cells Immobil Biotechnol 20:183–202 Riess JG (1992) Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Biomater Artif Cells Immobil Biotechnol 20:183–202
10.
Zurück zum Zitat Lowe KC (1999) Perfluorinated blood substitutes and artificial oxygen carriers. Blood Rev 13:171–184PubMedCrossRef Lowe KC (1999) Perfluorinated blood substitutes and artificial oxygen carriers. Blood Rev 13:171–184PubMedCrossRef
11.
Zurück zum Zitat Riess JG, Krafft MP (1998) Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery. Biomaterials 19:1529–1539PubMedCrossRef Riess JG, Krafft MP (1998) Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery. Biomaterials 19:1529–1539PubMedCrossRef
12.
Zurück zum Zitat Mattrey RF (1994) The potential use of Perflourochemicals (PFC’s) in diagnostic imaging. Artif cells, Blood Substit Immobil Biotechnol 22:295–313CrossRef Mattrey RF (1994) The potential use of Perflourochemicals (PFC’s) in diagnostic imaging. Artif cells, Blood Substit Immobil Biotechnol 22:295–313CrossRef
13.
Zurück zum Zitat Antonini E, Brunori M (1971) “Kinetics of the reactions of hemoglobin and myoglobin with ligands” Chapter 8 in: hemoglobin and myoglobin in their reactions with ligands. Frontiers of Biol, North-Holland Publishing Company 21:189–217 Antonini E, Brunori M (1971) “Kinetics of the reactions of hemoglobin and myoglobin with ligands” Chapter 8 in: hemoglobin and myoglobin in their reactions with ligands. Frontiers of Biol, North-Holland Publishing Company 21:189–217
14.
Zurück zum Zitat Ackers GK, Johnson ML (1981) Linked functions in allosteric proteins. J Mol Bio 147:559–582CrossRef Ackers GK, Johnson ML (1981) Linked functions in allosteric proteins. J Mol Bio 147:559–582CrossRef
15.
Zurück zum Zitat Benesch R, Benesch RE (1969) Intracellular organic phosphates as regulators of oxygen release by haemoglobin. Nature 221:618–622PubMedCrossRef Benesch R, Benesch RE (1969) Intracellular organic phosphates as regulators of oxygen release by haemoglobin. Nature 221:618–622PubMedCrossRef
16.
Zurück zum Zitat Antonini E, Condò SG, Giardina B, Ioppolo C, Bertollini A (1982) The effect of pH and d-glycerate 2,3 bisphosphate on the O2 equilibrium of normal and SH(_93)-modified human haemoglobin. Eur J Biochem 121:325–328PubMedCrossRef Antonini E, Condò SG, Giardina B, Ioppolo C, Bertollini A (1982) The effect of pH and d-glycerate 2,3 bisphosphate on the O2 equilibrium of normal and SH(_93)-modified human haemoglobin. Eur J Biochem 121:325–328PubMedCrossRef
18.
Zurück zum Zitat Kresie L (2001) Artificial blood: an update on current red cell and platelet substitutes. BUMC Proc 14:158–161 Kresie L (2001) Artificial blood: an update on current red cell and platelet substitutes. BUMC Proc 14:158–161
19.
Zurück zum Zitat Winslow RM (2006) Current status of oxygen carriers (‘blood substitutes’). Vox Sang 91:102–110PubMedCrossRef Winslow RM (2006) Current status of oxygen carriers (‘blood substitutes’). Vox Sang 91:102–110PubMedCrossRef
20.
Zurück zum Zitat Carson JL, Noveck H, Berlin JA, Gould SA (2002) Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 42:812–818PubMedCrossRef Carson JL, Noveck H, Berlin JA, Gould SA (2002) Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 42:812–818PubMedCrossRef
23.
Zurück zum Zitat Chang TMS (1971) Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Common 44:1531–1536CrossRef Chang TMS (1971) Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Common 44:1531–1536CrossRef
25.
Zurück zum Zitat Chang TMS. Blood substitutes: principles, methods, products and clinical trials. Vol.1 Basel Karger,1997. (full text and updates available at www.artcell.mcgill.ca) Chang TMS. Blood substitutes: principles, methods, products and clinical trials. Vol.1 Basel Karger,1997. (full text and updates available at www.​artcell.​mcgill.​ca)
26.
Zurück zum Zitat Gould SA, Moore EE, Hoyt DB, Ness PM, Norris EJ, Carson JL et al (2002) The life-sustaining capacity of human polymerized Hb when red cells might be unavailable. J Am Coll Surg 195:445–452PubMedCrossRef Gould SA, Moore EE, Hoyt DB, Ness PM, Norris EJ, Carson JL et al (2002) The life-sustaining capacity of human polymerized Hb when red cells might be unavailable. J Am Coll Surg 195:445–452PubMedCrossRef
27.
Zurück zum Zitat Pearce LB, Gawryl MS, Rentko VT, Moon-Massat PF, Rausch CW (2006) HBOC-201 (Hb Glutamer-250 (Bovine), Hemopure): clinical studies. In: Winslow R (ed) Blood substitutes. Academic Press, San Diego, pp 437–450CrossRef Pearce LB, Gawryl MS, Rentko VT, Moon-Massat PF, Rausch CW (2006) HBOC-201 (Hb Glutamer-250 (Bovine), Hemopure): clinical studies. In: Winslow R (ed) Blood substitutes. Academic Press, San Diego, pp 437–450CrossRef
28.
Zurück zum Zitat D’Agnillo F, Chang TMS (1998) PolyHb-superoxide dismutase. Catalase as a blood substitute with antioxidant properties. Nat Biotechnol 16:667–671PubMedCrossRef D’Agnillo F, Chang TMS (1998) PolyHb-superoxide dismutase. Catalase as a blood substitute with antioxidant properties. Nat Biotechnol 16:667–671PubMedCrossRef
29.
Zurück zum Zitat Chang TMS (1985) Artificial cells with regenerating multienzyme systems. Meth Enzymol 112:195–203PubMedCrossRef Chang TMS (1985) Artificial cells with regenerating multienzyme systems. Meth Enzymol 112:195–203PubMedCrossRef
30.
Zurück zum Zitat Gu KF, Chang TMS (1988) Conversion of ammonia or urea into l-leucine, l-valine and l-isoleucine using artificial cell immobilising multienzyme system and dextran-NADH+. I. Glucose dehydrogenase for cofactor recycling. J Am Soc Artif Intern Organs 11:24–28 Gu KF, Chang TMS (1988) Conversion of ammonia or urea into l-leucine, l-valine and l-isoleucine using artificial cell immobilising multienzyme system and dextran-NADH+. I. Glucose dehydrogenase for cofactor recycling. J Am Soc Artif Intern Organs 11:24–28
31.
Zurück zum Zitat Chang TMS, Powanda D, Yu WP (2003) Ultrathin polyethylene-glycolpolylactide copolymer membrane nanocapsules containing polymerized Hb and enzymes as nano-dimension red blood cell substitutes. Artif Cells Blood Substit Biotechnol 3:231–248CrossRef Chang TMS, Powanda D, Yu WP (2003) Ultrathin polyethylene-glycolpolylactide copolymer membrane nanocapsules containing polymerized Hb and enzymes as nano-dimension red blood cell substitutes. Artif Cells Blood Substit Biotechnol 3:231–248CrossRef
32.
Zurück zum Zitat Djordjevich L, Miller IF (1980) Synthetic erythrocytes from lipid encapsulated Hb. Exp Hematol 8:584PubMed Djordjevich L, Miller IF (1980) Synthetic erythrocytes from lipid encapsulated Hb. Exp Hematol 8:584PubMed
33.
Zurück zum Zitat Philips WT, Klpper RW, Awasthi VD, Rudolph AS, Cliff R, Kwasiborski VV et al (1999) Polyethylene glyco-modified liposome-encapsulated Hb: a long circulating red cell substitute. J Pharm Exp Therapeutics 288:665–670 Philips WT, Klpper RW, Awasthi VD, Rudolph AS, Cliff R, Kwasiborski VV et al (1999) Polyethylene glyco-modified liposome-encapsulated Hb: a long circulating red cell substitute. J Pharm Exp Therapeutics 288:665–670
34.
Zurück zum Zitat Chang TMS (1976) Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals. J Bioengineering 1:25–32 Chang TMS (1976) Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals. J Bioengineering 1:25–32
35.
Zurück zum Zitat Yu WP, Chang TMS (1994) Submicron biodegradable polymer membrane Hb nanocapsules as potential blood substitutes: a preliminary report. Artif Cells Blood Substit Immobil Biotechnol 22:889–894PubMedCrossRef Yu WP, Chang TMS (1994) Submicron biodegradable polymer membrane Hb nanocapsules as potential blood substitutes: a preliminary report. Artif Cells Blood Substit Immobil Biotechnol 22:889–894PubMedCrossRef
36.
Zurück zum Zitat Yu WP, Chang TMS (1996) Submicron biodegradable polymer membrane Hb nanocapsules as potential blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 24:169–184PubMedCrossRef Yu WP, Chang TMS (1996) Submicron biodegradable polymer membrane Hb nanocapsules as potential blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 24:169–184PubMedCrossRef
37.
Zurück zum Zitat Chang TMS, Yu WP, Yu WP (1998) Nanoencapsulation of Hb and RBC enzymes based on nanotechnology and biodegradable polymer. In: Chang TMS (ed) Blood substitutes: principles, methods, products and clinical trials, vol 2. Karger, Basel, pp 216–231 Chang TMS, Yu WP, Yu WP (1998) Nanoencapsulation of Hb and RBC enzymes based on nanotechnology and biodegradable polymer. In: Chang TMS (ed) Blood substitutes: principles, methods, products and clinical trials, vol 2. Karger, Basel, pp 216–231
Metadaten
Titel
Blood Substitutes: Possibilities with Nanotechnology
verfasst von
Feroz Alam
Neha Yadav
Murad Ahmad
Mariyam Shadan
Publikationsdatum
01.09.2014
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 3/2014
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-013-0309-5

Weitere Artikel der Ausgabe 3/2014

Indian Journal of Hematology and Blood Transfusion 3/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.